Harold Farber, MD, MSPH, from the Texas Children's Hospital, discusses the new requirement for tobacco companies to publish corrective statements regarding the dangers of their products.
In this podcast, Ana-Maria Orbai, MD, MHS, talks about the interchangeability between the HAQ-DI and PROMIS-PF in the measurement of minimal disease activity among patients with psoriatic arthritis and how...
In part 4 of this 4-part series, Dr Paul Mather from University of Pennsylvania's Perelman School of Medicine talks about candidates for mechanical support devices, the history of the major devices in...
Dr May, from the University of California, Los Angeles, discusses her research about disparities in colorectal cancer (CRC) screening, how gastroenterologists can help improve CRC screening rates in the...
Dr Merrill discusses her research that evaluated different serologic features to encourage more entry in lupus clinical trials of individuals with active disease, and more.
